Biotoxtech Co. Ltd (086040) — Cash Flow-to-Debt Ratio
Biotoxtech Co. Ltd (086040) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of ₩-354.72 Million could theoretically repay 0% of its total liabilities (₩98.39 Billion) in one year. See free cash flow generation of Biotoxtech Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biotoxtech Co. Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Biotoxtech Co. Ltd across 13 annual periods. Also explore net asset momentum of Biotoxtech Co. Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biotoxtech Co. Ltd (2011–2024)
Year-by-year debt coverage analysis for Biotoxtech Co. Ltd. For market capitalisation and broader financial context, see market cap of Biotoxtech Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.07x | ₩-7.12 Billion | ₩96.11 Billion | ▲ +54.9% |
| 2023 | -0.16x | ₩-16.24 Billion | ₩98.80 Billion | ▼ -922.8% |
| 2022 | -0.02x | ₩-1.31 Billion | ₩81.47 Billion | ▼ -118.3% |
| 2021 | 0.09x | ₩4.35 Billion | ₩49.60 Billion | ▼ -42.1% |
| 2020 | 0.15x | ₩4.56 Billion | ₩30.13 Billion | ▲ +214.5% |
| 2019 | 0.05x | ₩1.44 Billion | ₩29.98 Billion | ▼ -49.8% |
| 2018 | 0.10x | ₩3.06 Billion | ₩31.88 Billion | ▼ -47.1% |
| 2017 | 0.18x | ₩6.02 Billion | ₩33.18 Billion | ▼ -19.4% |
| 2016 | 0.23x | ₩5.28 Billion | ₩23.47 Billion | ▲ +714.8% |
| 2015 | -0.04x | ₩-798.17 Million | ₩21.79 Billion | ▲ +62.2% |
| 2014 | -0.10x | ₩-2.05 Billion | ₩21.15 Billion | ▼ -211.3% |
| 2012 | 0.09x | ₩1.63 Billion | ₩18.75 Billion | ▼ -40.5% |
| 2011 | 0.15x | ₩3.28 Billion | ₩22.45 Billion | — |